Aquinox Pharma (AQXP) Posts Narrower-than-Expected Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results
November 10, 2015 9:15 AM ESTVANCOUVER, British Columbia, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Aquinox) (NASDAQ: AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today provided a corporate update and... More
Aquinox Pharmaceuticals Reports Third Quarter 2015 Financial Results
November 10, 2015 9:15 AM ESTVANCOUVER, British Columbia, Nov. 10, 2015 (GLOBE NEWSWIRE) -- Aquinox Pharmaceuticals, Inc. (Aquinox) (NASDAQ: AQXP), a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology, today provided a corporate update and... More
